Showing 1 to 10 of 1,963
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| COVID 19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 | Reference number:ES27 | ES00027 | Published:05 June 2020 | 20200605 | Last updated:05 June 2020 | 20200605 |
| Joint replacement (primary): hip, knee and shoulder | Reference number:NG157 | NG00157 | Published:04 June 2020 | 20200604 | Last updated:04 June 2020 | 20200604 |
| Fremanezumab for preventing migraine | Reference number:TA631 | TA00631 | Published:03 June 2020 | 20200603 | Last updated:03 June 2020 | 20200603 |
| Larotrectinib for treating NTRK fusion-positive solid tumours | Reference number:TA630 | TA00630 | Published:27 May 2020 | 20200527 | Last updated:27 May 2020 | 20200527 |
| COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 | Reference number:ES24 | ES00024 | Published:21 May 2020 | 20200521 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 | Reference number:ES25 | ES00025 | Published:21 May 2020 | 20200521 | Last updated:21 May 2020 | 20200521 |
| COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis | Reference number:ES26 | ES00026 | Published:21 May 2020 | 20200521 | Last updated:21 May 2020 | 20200521 |
| Cytokine adsorption devices for treating respiratory failure in people with COVID-19 | Reference number:MIB217 | MIB00217 | Published:21 May 2020 | 20200521 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid guideline: children and young people who are immunocompromised | Reference number:NG174 | NG00174 | Published:01 May 2020 | 20200501 | Last updated:21 May 2020 | 20200521 |
| COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders | Reference number:NG167 | NG00167 | Published:03 April 2020 | 20200403 | Last updated:21 May 2020 | 20200521 |